News >

Gene Expression Studies Offer Insight Into Myeloma Regimen's Efficacy

Published: Monday, Dec 19, 2016

Alessandra Di Bacco, PhD

Alessandra Di Bacco, PhD

An analysis of c-MYC expression in relapsed myeloma identified subgroups of patients with improved response to the combination of an immunomodulator and a proteasome inhibitor, according to data from a randomized trial presented during the 2016 ASH Annual Meeting.1
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Community Practice Connections™: Advancing the Treatment of Bladder Cancers Using Evidence-Based Immuno-Oncology StrategiesJul 30, 20191.0
Medical Crossfire®: Where Are We Headed in the Treatment of Triple-Negative Breast Cancer?Jul 31, 20191.5
Publication Bottom Border
Border Publication
x